Efficacy, safety of hydroxychloroquine vs placebo to prevent SARS-CoV-2 infection among health care
What The Study Did: In this randomized clinical trial, daily hydroxychloroquine didn’t prevent SARS-CoV-2 infection among hospital-based health care workers, although the trial was terminated early.
Authors: Ravi K. Amaravadi, M.D., of the University of Pennsylvania in Philadelphia, is the corresponding author.
To access the embargoed study: Visit our For The Media website at this link https:/
Editor’s Note: The article includes conflict of interest and funding/support disclosures. Please see the article for additional information, including other authors, author contributions and affiliations, conflict of interest and financial disclosures, and funding and support.
Media advisory: The full study is linked to this news release.
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https:/
JAMA Network Media Relations